Stocks Health care ESMC
OTC · Health careEscalon Medical Corp (ESMC)
Escalon Medical Corp brought in $11.4M of revenue over the twelve months to March 31, 2026, down 11.6% from a year earlier. Net income was $1.9M, a net margin of 16.2%. Operating cash flow minus capital spending left $376.8K of free cash flow in fiscal 2025. At March 31, 2026 it held $3.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 15, 2026.
Watch ESMC in 60 secondsWhat Escalon Medical Corp does
Escalon Medical Corp is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on OTC under the ticker ESMC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $12M | $105.5K | $0.00 | $376.8K |
| 2024 | $12M | -$125.3K | -$0.02 | -$643.1K |
| 2023 | $12.2M | $456.8K | $0.03 | $318.5K |
| 2022 | $10.7M | $18.1K | $0.00 | -$1M |
| 2021 | $10.5M | -$52K | -$0.01 | $829.3K |
| 2020 | $9.4M | -$650.3K | -$0.09 | -$228.2K |
Full financial statements: income, balance sheet and cash flow
Where ESMC ranks in Health care
Latest SEC filings
What Escalon Medical Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 25% to $2.6M versus the same quarter last year; diluted EPS $0.16 versus $0.02.
- April 9, 2026Passive stake (5% or more) SCHEDULE 13G
- February 17, 2026Quarterly report 10-Q · period to December 31, 2025Revenue rose 12% to $3.6M versus the same quarter last year; diluted EPS $0.01 versus $0.02.
- January 29, 2026
- November 14, 2025Quarterly report 10-Q · period to September 30, 2025Revenue fell 3.8% to $2.7M versus the same quarter last year; diluted EPS -$0.03 versus -$0.01.
- October 6, 2025Passive stake changed SCHEDULE 13G/A
- September 29, 2025Annual report 10-K · period to June 30, 2025Revenue rose 0.5% to $12M versus the prior year; diluted EPS $0.00 versus -$0.02.
- July 8, 2025Passive stake changed SCHEDULE 13G/A
- May 23, 2025Passive stake (5% or more) SCHEDULE 13G
- May 23, 2025Passive stake (5% or more) SCHEDULE 13G
What is ESMC worth? A DCF from its reported cash flow
Who owns ESMC
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| LPL Financial LLC13G, passive | 7.9% | April 9, 2026 |
Largest institutional holders
Insiders
Questions about ESMC
What does Escalon Medical Corp do?
Escalon Medical Corp is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on OTC under the ticker ESMC.
Is Escalon Medical Corp profitable?
Yes. Over the twelve months to March 31, 2026 it reported net income of $1.9M on revenue of $11.4M, a net margin of 16.2%.
How much revenue does Escalon Medical Corp make?
Over the twelve months to March 31, 2026 Escalon Medical Corp reported revenue of $11.4M. That is 11.6% less than a year earlier.
When did Escalon Medical Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on May 15, 2026. It covers the period to March 31, 2026.
Similar companies
Compare ESMC with
Follow ESMC
Get an email when Escalon Medical Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow ESMC: get an email when it filesWhere the numbers come from
Financial figures are the values Escalon Medical Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.